Physician profile
Augusto E Tirado
NPI 1619940665
$4,365.64
in general payments reported to CMS, 2019-2025
23 companies · $734 in 2025
The $734 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $391 · 2021: $512 · 2022: $1,052 · 2023: $930 · 2024: $119 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.35 |
| Education | $177.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $639.45 | 2022-2025 | Aquabeam Robotic System |
| Teleflex LLC | $601.27 | 2021-2024 | Urolift |
| Myriad Genetic Laboratories, INC. | $550.71 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $548.08 | 2019-2023 | Veozah |
| Janssen Biotech, INC. | $533.81 | 2022-2025 | Erleada, Rybrevant, Carvykti |
| Axonics, INC. | $380.77 | 2020-2024 | Axonics |
| Pfizer INC. | $235.34 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $213.11 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $161.15 | 2020-2023 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $114.80 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $84.78 | 2020-2021 | |
| Neotract INC. | $66.91 | 2019 | |
| Boston Scientific Corporation | $33.70 | 2020 | |
| Alexion Pharmaceuticals, INC. | $29.00 | 2025 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $26.71 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $23.43 | 2025 | Irrisept |
| Myovant Sciences INC. | $23.33 | 2021 | |
| Olympus America INC. | $20.55 | 2023 | Itind System |
| Allergan, INC. | $18.18 | 2020 | |
| Urogen Pharma, INC. | $17.45 | 2022 | |
| Travere Therapeutics, INC. | $16.03 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $15.48 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augusto Tirado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.